Concepedia

Richard Sharp

RS

Statistics

Publications

15

Citations

1.9K

H-Index

15

Active since

1992

Affiliations

National Cancer Institute(Current)

National Institutes of Health

Science Applications International Corporation (United States)

Augusta University

Austin Hospital

Richard Sharp is an author at National Cancer Institute specializing in medicine, growth factor signaling, and transgenic mice.

Publications per year

1992–2008

15

Publications

15

Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor

Hisashi Takayama, William J. LaRochelle, Richard Sharp et al. · Proceedings of the National Academy of Sciences · 1997 · 439 citations · Full text

, , +17

C-Met Autocrine Activation Induces Development Of Malignant Melanoma And Acquisition Of The Metastatic Phenotype

Toshiyuki Otsuka, Hisashi Takayama, Richard Sharp et al. · PubMed · 1998 · 269 citations · Full text

, , +17

Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.

Daniel Gallahan, Chamelli Jhappan, Gertraud W. Robinson et al. · PubMed · 1996 · 175 citations

, , +15

Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis

Richard Sharp, Juan A. Recio, Chamelli Jhappan et al. · Nature Medicine · 2002 · 157 citations

, , +14

Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers.

Hiromi Sakata, Hisashi Takayama, Richard Sharp et al. · PubMed · 1996 · 153 citations

, , +16

1–5 of 15